ストックスクリーナーアプリを入手
33.54
5.44%
-1.93
アフターアワーズ：
33.28
-0.26
-0.78%
前日終値:
$35.47
開ける：
$34.63
24時間の取引高:
22.79M
Relative Volume:
0.87
時価総額：
$7.76B
収益：
$2.35B
当期純損益:
$128.37M
株価収益率:
64.24
EPS:
0.5221
ネットキャッシュフロー:
$57.42M
1週間 パフォーマンス:
+11.17%
1か月 パフォーマンス:
+41.22%
6か月 パフォーマンス:
-4.31%
1年 パフォーマンス:
-47.77%
1日の値動き範囲:
$33.30
$35.99
1週間の範囲:
$29.68
$35.99
52週間の値動き範囲:
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Compare HIMS vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
33.54 | 8.21B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
15.47 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.77 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.20 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.89 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
538.30 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-24 | 開始されました | JP Morgan | Overweight |
| 2026-03-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2026-03-10 | アップグレード | Citigroup | Sell → Neutral |
| 2026-03-09 | アップグレード | Needham | Hold → Buy |
| 2026-02-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2026-01-12 | 開始されました | Evercore ISI | In-line |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
A Look at Hims & Hers Health Inc (HIMS) After 5.4% Decline -- GF Value $38.53 vs Price $33.54 - GuruFocus
HIMS Stock Logs Best Day In 2 Months: Bull Sees Peptides Driving Up To $19B In Annual Revenue By 2030 - Stocktwits
Telehealth platform names Dr. Anant Vinjamoori as Hims CMO - The American Bazaar
HIMS Stock Slides Overnight: Insider Files Share Sale As CEO Teases Oura Wearable Integration - Stocktwits
HIMS Stock Gained Nearly 6% On Wednesday — Barclays Sees Breakout Potential After Novo Partnership - Stocktwits
Manchester-Hampstead - dailyvoice.com
Hims & Hers Health (HIMS) Q1 2026 earnings summary - Quartr
Hims & Hers Stock Fell 78% From Its Peak: What Comes After the GLP-1 Unwind - TIKR.com
HIMS Stock On The Mend? New Testosterone Push Builds As GLP-1 Gold Rush Gets Crowded - Stocktwits
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hims & Hers Health Inc (HIMS) Shares Surge 11.2% -- What GF Scor - GuruFocus
HIMS Shows Strong Bullish Momentum with Notable Stock Surge - GuruFocus
Hims & Hers Health Options Spot-On: On June 18th, 307.22K Contracts Were Traded, With 1.13 Million Open Interest - Moomoo
HIMS (NYSE) Form 144: 12,500 and 11,226 vested Class A shares listed - Stock Titan
Hims & Hers Stock Jumps After Barclays Raises Price Target - Benzinga
Hims & Hers Rallies With a July FDA Decision Looming - TradingView
HIMS Maintained by Barclays -- Price Target Raised to $39.00 - GuruFocus
Hims & Hers Health gains as investors appear to lean into growth outlook and global expansion - Quiver Quantitative
Closed all position, was too greedy aiming for highest 34.65 ended up earned a bit lesser - Moomoo
Why is Hims & Hers Health stock surging today? - Investing.com
Hims & Hers: The Bull Case Remains Strong (NYSE:HIMS) - Seeking Alpha
$Hims & Hers Health (HIMS.US)$ sold 80% holding to take profit @ $35 [Cool Guy] Believe - Moomoo
Hims & Hers Health: Legal Risks Resolved With New International Growth DriverMaintain Buy - Seeking Alpha
Hims & Hers Health, Inc. (HIMS) ascends while market falls: Some facts to note - MSN
Hims & Hers COO Michael Chi sells $441,850 in company stock By Investing.com - Investing.com South Africa
Hims & Hers (HIMS) CMO logs RSU vesting and tax share withholding - Stock Titan
Hims & Hers (NYSE: HIMS) CFO exercises RSUs as shares withheld for tax - Stock Titan
Hims & Hers (HIMS) exec nets shares after 32,919 RSU conversion - Stock Titan
Hims & Hers (NYSE: HIMS) COO sells 14,027 shares, holds 432,124 - Stock Titan
Hims & Hers (NYSE: HIMS) PAO trades shares under 10b5-1 plan - Stock Titan
[Form 4] Hims & Hers Health, Inc. Insider Trading Activity - Stock Titan
Hims & Hers (NYSE: HIMS) CEO exercises RSUs and withholds shares for taxes - Stock Titan
Hims & Hers Health (HIMS) CTO exercises awards and sells 30,040 shares - Stock Titan
Hims & Hers Health, Inc. (HIMS) Ascends While Market Falls: Some Facts to Note - Yahoo Finance Singapore
Hims & Hers Health (HIMS) up 15.8% since last earnings report: Can it continue? - MSN
Hims & Hers Health Options Spot-On: On June 17th, 198.05K Contracts Were Traded, With 1.1 Million Open Interest - Moomoo
Hims & Hers Health Stock (HIMS) Opinions on Market Momentum - Quiver Quantitative
$Hims & Hers Health (HIMS.US)$ Very good—continue holding - Moomoo
Hims Holdings (HIMS) Form 144: Director lists proposed sale of Class A shares - Stock Titan
[144] Hims & Hers Health, Inc. SEC Filing - Stock Titan
HIMS (NYSE) Form 144 shows insiders propose selling 14,027 and 97,289 Class A shares - Stock Titan
HIMS Stock Breaks Above $30 Ahead Of Upcoming FDA Peptide Review: Analysts Eye Next Growth Catalyst - Yahoo Finance
$Hims & Hers Health (HIMS.US)$ make or break. burst open this 31 dollar line with solid candle plz - Moomoo
Hims & Hers Enters A New Phase (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Inc (HIMS) Stock Up 4.3% and Still Undervalued -- GF Score: 81/100 - GuruFocus
Hims & Hers Health Options Spot-On: On June 16th, 184.32K Contracts Were Traded, With 1.08 Million Open Interest - Moomoo
Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides Market - Barron's
Hims & Hers Stock Is Climbing Tuesday: What Investors Need To Know - Benzinga
Insider sells 5,529 Class A shares at HIMS (HIMS) via Fidelity - Stock Titan
Leerink reiterates Hims & Hers stock rating ahead of peptide meeting - Investing.com
3 Market-Beating Stocks with Exciting Potential - The Globe and Mail
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
4.67%
1.32%
大文字化:
|
ボリューム (24 時間):